These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 15213312

  • 1. Azithromycin for improving pulmonary function in cystic fibrosis.
    Carr RR, Nahata MC.
    Ann Pharmacother; 2004 Sep; 38(9):1520-4. PubMed ID: 15213312
    [Abstract] [Full Text] [Related]

  • 2. Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: long-term outcomes related to macrolide resistance and pulmonary function.
    Tramper-Stranders GA, Wolfs TF, Fleer A, Kimpen JL, van der Ent CK.
    Pediatr Infect Dis J; 2007 Jan; 26(1):8-12. PubMed ID: 17195698
    [Abstract] [Full Text] [Related]

  • 3. Improved lung function and body mass index associated with long-term use of Macrolide antibiotics.
    Pirzada OM, McGaw J, Taylor CJ, Everard ML.
    J Cyst Fibros; 2003 Jun; 2(2):69-71. PubMed ID: 15463852
    [Abstract] [Full Text] [Related]

  • 4. Once-weekly azithromycin in cystic fibrosis with chronic Pseudomonas aeruginosa infection.
    Steinkamp G, Schmitt-Grohe S, Döring G, Staab D, Pfründer D, Beck G, Schubert R, Zielen S.
    Respir Med; 2008 Nov; 102(11):1643-53. PubMed ID: 18701270
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of azithromycin in plasma, blood, polymorphonuclear neutrophils and sputum during long-term therapy in patients with cystic fibrosis.
    Wilms EB, Touw DJ, Heijerman HG.
    Ther Drug Monit; 2006 Apr; 28(2):219-25. PubMed ID: 16628134
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study.
    Hansen CR, Pressler T, Koch C, Høiby N.
    J Cyst Fibros; 2005 Mar; 4(1):35-40. PubMed ID: 15752679
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical response to azithromycin in cystic fibrosis correlates with in vitro effects on Pseudomonas aeruginosa phenotypes.
    Nguyen D, Emond MJ, Mayer-Hamblett N, Saiman L, Marshall BC, Burns JL.
    Pediatr Pulmonol; 2007 Jun; 42(6):533-41. PubMed ID: 17469154
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Exploring the mechanisms of macrolides in cystic fibrosis.
    Equi AC, Davies JC, Painter H, Hyde S, Bush A, Geddes DM, Alton EW.
    Respir Med; 2006 Apr; 100(4):687-97. PubMed ID: 16185859
    [Abstract] [Full Text] [Related]

  • 13. [Macrolides, Pseudomonas aeruginosa and cystic fibrosis].
    Guillot M, Amiour M, El Hachem C, Harchaoui S, Ribault V, Paris C.
    Arch Pediatr; 2006 Oct; 13 Suppl 1():S48-50. PubMed ID: 17370396
    [Abstract] [Full Text] [Related]

  • 14. Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients.
    Hansen CR, Pressler T, Hoiby N, Johansen HK.
    J Cyst Fibros; 2009 Jan; 8(1):58-62. PubMed ID: 18849202
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Open-label, follow-on study of azithromycin in pediatric patients with CF uninfected with Pseudomonas aeruginosa.
    Saiman L, Mayer-Hamblett N, Anstead M, Lands LC, Kloster M, Goss CH, Rose LM, Burns JL, Marshall BC, Ratjen F, AZ0004 Macrolide Study Team.
    Pediatr Pulmonol; 2012 Jul; 47(7):641-8. PubMed ID: 22684984
    [Abstract] [Full Text] [Related]

  • 17. [Effects of azithromycin on the virulence of Pseudomonas aeruginosa].
    Reinert P.
    Pathol Biol (Paris); 1995 Jun; 43(6):551-3. PubMed ID: 8539081
    [Abstract] [Full Text] [Related]

  • 18. Aztreonam inhalation solution for suppressive treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.
    Assael BM.
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):967-73. PubMed ID: 22029514
    [Abstract] [Full Text] [Related]

  • 19. Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis.
    Phaff SJ, Tiddens HA, Verbrugh HA, Ott A.
    J Antimicrob Chemother; 2006 Apr; 57(4):741-6. PubMed ID: 16469851
    [Abstract] [Full Text] [Related]

  • 20. The use of macrolide antibiotics in patients with cystic fibrosis.
    Saiman L.
    Curr Opin Pulm Med; 2004 Nov; 10(6):515-23. PubMed ID: 15510060
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.